The opinion of the Committee

The opinion of the Committee, the European Commission, which make make a final decision on the authorization . The Commission has 66 calendar days to act on the CHMP’s opinion.In the EU, Mozobil would be indicated in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma whose cells mobilize poor poor. ‘For many patients with lymphoma or multiple myeloma, is shifting to a transplant her only hope for remission or a cure,’said Gerhard Ehninger, days.essor of medicine at the Dresden Technology University and Chairman of the German Society of Hematology and Oncology. ‘Mozobil is an innovative treatment, after the approval these patients these patients an opportunity to achieve a timely and successful transplant. ‘.

Genzyme received FDA approval of Mozobil in December 2008. The company plans to submit additional applications in up to 60 countries.About MozobilMozobil, a novel small molecule CXCR4 chemokine receptor antagonist, in several previous studies it was shown quickly and effectively multiple the number of stem cells circulating in the blood in patients with non-Hodgkin’s lymphoma and myeloma. Once that can circulate in the blood stem cells for use in autologous stem cell transplantation are collected.

According to John to all, Vatican correspondent for the National Catholic Reporter, will help cultural differences of the U.S. And Europe Catholic views about abortion to explain their opposite approaches to the subject. Said that said that abortions is typically ‘the determining social and political issue ‘in the U.S., and that ‘all in such a way in second place. ‘European ‘, the the case, the case, ‘and ‘even the conservative Catholics of Europe. Not evaluate leaders exclusively by the account of their positions of on abortion and other so-called life of issues,’said Allen (Poggioli, ‘Morning Edition ‘.